Graham Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Graham Capital Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$310K	Sell	8,555 -1,431	-14%	-$48.9K	0.01%	886
2026 Q1	$330K	Buy	9,986 +2,996	+43%	+$127K	0.01%	782
2025 Q4	$324K	Buy	+6,990	New	+$292K	0.01%	827
2024 Q3	–	Sell	-17,341	Closed	-$558K	–	1133
2024 Q2	$558K	Buy	17,341 +5,095	+42%	+$177K	0.01%	545
2024 Q1	$475K	Buy	12,246 +4,683	+62%	+$164K	0.01%	640
2023 Q4	$233K	Sell	7,563 -8,044	-52%	-$202K	0.01%	797
2023 Q3	$349K	Buy	15,607 +5,503	+54%	+$126K	0.01%	672
2023 Q2	$217K	Sell	10,104 -5,256	-34%	-$119K	0.01%	791
2023 Q1	$368K	Buy	+15,360	New	+$407K	0.01%	824

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Graham Capital Management's COLL Position: Q2 2026 in Review

Graham Capital Management reduced its Collegium Pharmaceutical (COLL) stake by 14% in Q2 2026, selling an estimated $48.9K and leaving 8,555 shares worth $310K. The position accounts for 0.01% of the portfolio, ranked #886.

Graham Capital Management first reported a position in COLL in Q1 2023 and has held it in 9 quarters since. The position peaked at $558K in Q2 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Graham Capital Management held 8,555 shares of Collegium Pharmaceutical worth $310K as of Q2 2026.
Graham Capital Management sold 1,431 Collegium Pharmaceutical shares in Q2 2026, an estimated $48.9K.
Collegium Pharmaceutical made up 0.01% of Graham Capital Management's portfolio in Q2 2026, its #886 holding.
Graham Capital Management first reported a position in Collegium Pharmaceutical in Q1 2023 and has held it in 9 quarters since.
Graham Capital Management's Collegium Pharmaceutical position peaked at $558K in Q2 2024.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.